vimarsana.com

நிறுவனங்கள் அடிப்படையிலானது இல் அஹமதாபாத் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Benchmarks off the day s low

Read more about Benchmarks off the day s low on Business Standard. The domestic equity benchmarks pared early losses in morning trade. The Nifty was trading below the 15,750 mark. Adani Group stocks crashed.

Cadila Healthcare Ltd soars 1 24%, Gains for third straight session

Cadila Healthcare Ltd is quoting at Rs 635.2, up 1.24% on the day as on 12:49 IST on the NSE. The stock is up 75.13% in last one year as compared to a 55.93% gain in NIFTY and a 40.15% gain in the Nifty Pharma index. Cadila Healthcare Ltd is up for a third straight session in a row. The stock is quoting at Rs 635.2, up 1.24% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.4% on the day, quoting at 15638.4. The Sensex is at 52049.43, up 0.39%. Cadila Healthcare Ltd has added around 11.61% in last one month. Meanwhile, Nifty Pharma index of which Cadila Healthcare Ltd is a constituent, has added around 6.72% in last one month and is currently quoting at 14151.85, down 0.2% on the day. The volume in the stock stood at 27.72 lakh shares today, compared to the daily average of 98.83 lakh shares in last one month.

Zydus Cadila receives USFDA tentative approval for Osimertinib Tablets

Read more about Zydus Cadila receives USFDA tentative approval for Osimertinib Tablets on Business Standard. Osimertinib is used to treat lung cancer. It belongs to a class of drugs known as kinase inhibitors. Osimertinib works by slowing or stopping the growth of cancer cells. It binds to a certain protein (epidermal growth factor receptor-EGFR) in some

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.